Study of value of TCT, human papillomavirus DNA and colposcopy in the early screening of cervical cancer
10.3969/j.issn.1005-1678.2017.08.158
- VernacularTitle:TCT、人乳头瘤病毒DNA检查联合阴道镜检查在宫颈癌早期筛查中的价值研究
- Author:
Minyan LI
- Keywords:
TCT;
human papillomavirus DNA examination;
colposcopy;
cervical cancer;
early screening;
value
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(8):369-371
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the value of TCT, human papillomavirus DNA combined with colposcopy in the early screening of cervical cancer. Methods The clinical data of 80 cases of patients with cervical lesions in our hospital from January 2011 to January 2017 were retrospectively analyzed. Results Among the 80 cases of patients, ASCUS was detected by TCT 8 cases, LSIL6 cases, HSIL4 cases, SCC2 cases, the detection rate of cervical lesions was 25.0% (20/80); Normal and inflammatory 60 cases, accounting for 75.0% (60/80) of the total. HPV-DNA positive 28 cases, negative 52 cases, the positive rate was 35.0% (28/80); The detection rate of TCT (+) HPV (+) was significantly higher than TCT (+) HPV (-), TCT (-) HPV (+), TCT (-) HPV (-) (P<0.05), the detection rate of SCC reached 100.0%; The detection rate of CIN I, CIN II, CIN III of TCT examination, HPV-DNA examination combined with colposcopy were significantly higher than TCT+HPV-DNA examination (P<0.05), but the difference of detection rates of SCC between the two was not significant. Conclusion The value of TCT, human papillomavirus DNA and colposcopy in the early screening of cervical cancer is higher, so is worthy of promotion and use in the clinical.
